<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01181791</url>
  </required_header>
  <id_info>
    <org_study_id>20090924</org_study_id>
    <nct_id>NCT01181791</nct_id>
  </id_info>
  <brief_title>Effects of Lactobacillus Reuteri in Premature Infants</brief_title>
  <acronym>Reuteri</acronym>
  <official_title>Pilot Study to Evaluate the Effects of Lactobacillus Reuteri in Preterm Newborns</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Miami</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Pontificia Universidad Catolica de Chile</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Miami</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This application a phase II clinical trial to address the possible active mechanisms of
      probiotics and to obtain preliminary efficacy and safety data after the administration of a
      probiotic, Lactobacillus reuteri a population of premature infants.

      The hypothesis is that the exogenous supplementation Lactobacillus reuteri to premature
      infants will lead to clinical beneficial effects by modifying their intestinal microbiota and
      enhancing their intestinal immunological response.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary outcome &quot;days to achieve full feeds&quot; will be measure during the the first month
      of life Secondary outcomes will be measured at baseline (before intervention), 3 weeks after
      intervention, once intervention discontinued and at 6 months of live
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Poor recruitment
  </why_stopped>
  <start_date>July 2010</start_date>
  <completion_date type="Actual">July 2017</completion_date>
  <primary_completion_date type="Actual">July 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Administration of probiotic Lactobacillus Reuteri</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
    <masking_description>Administration of placebo</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Time to reach full feeds</measure>
    <time_frame>First 40 days after birth</time_frame>
    <description>Days to reach full feeds from the day feeds are started</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intestinal colonization</measure>
    <time_frame>0-6 months after birth</time_frame>
    <description>PCR quantification of lactobacillus reuteri in the stools</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intestinal immunological response</measure>
    <time_frame>0-6 months</time_frame>
    <description>Quantification immunological markers in the stools</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">65</enrollment>
  <condition>Premature Infant Disease</condition>
  <arm_group>
    <arm_group_label>probiotic group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Lactobacillus reuteri will be given at a dose of 1x108 colony forming units (CFU)/day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The placebo consists of an identical formulation except that the L. reuteri is not present.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Lactobacillus reuteri</intervention_name>
    <description>Lactobacillus reuteri DSM will be given at a dose of 1x108 colony forming units (CFU)/day</description>
    <arm_group_label>probiotic group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>The placebo consists of an identical formulation except that the L. reuteri is not present.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Preterm newborns admitted to the neonatal intensive care units with a birth weight
             700-1500 g and who survive more than 3 days

        Exclusion Criteria:

          -  Chromosomal anomalies.

          -  Major congenital anomalies (complex cardiac anomalies, congenital hydrocephalus, renal
             dysplasia)

          -  Congenital (e.g. jejunal atresia) and acquired (e.g. GI perforation) gastrointestinal
             pathology precluding oral feed and/or requiring major surgical or medical intervention

          -  Parental refusal

          -  Prior enrollment into a conflicting clinical trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>6 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Teresa del Moral, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Miami</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Sotero del Rio</name>
      <address>
        <city>Santiago</city>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pontifica Universidad Catolica</name>
      <address>
        <city>Santiago</city>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Chile</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 2, 2010</study_first_submitted>
  <study_first_submitted_qc>August 12, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 13, 2010</study_first_posted>
  <last_update_submitted>August 24, 2017</last_update_submitted>
  <last_update_submitted_qc>August 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 28, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Miami</investigator_affiliation>
    <investigator_full_name>Teresa del Moral</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>probiotics</keyword>
  <keyword>premature infants</keyword>
  <keyword>feeding tolerance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Premature Birth</mesh_term>
    <mesh_term>Infant, Premature, Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

